瑞典人犁200克朗研究抗糖尿病食品

瑞典政府機構為創新係統、VINNOVA已經宣布它將犁克朗2億(€2190萬)中心,旨在促進研究抗糖尿病的食物。“事實上,我們已經給予金融支持區域內的工作對每個人來說都是非常幸運的。這也意味著很多公共衛生和食品行業,“荷蘭國際集團(ing)教授說Bjorck,中心。中心的使命是為新的理解食品旨在減少肥胖,2型糖尿病和心血管疾病。此外,瑪麗亞·約翰遜,項目經理隆德大學的功能食品科學中心,告訴NutraIngredients.com,該研究計劃將遵循特定的領域:臨床文檔的功效的食物組合在胰島素抵抗綜合征(IRS)風險因素;食品設計利用腸道微生物生態係統的關係和國稅局風險因素;食品設計利用營養物質和生物活性成分的生物利用度與國稅局;和體重/食欲。估計有1900萬人受糖尿病影響歐盟25個,相當於總人口的百分之四。這個數字在2030年預計將增加到2600萬。在美國,有超過2000萬人患有糖尿病,等於百分之七的人口。總成本被認為是多達1320億美元,從藥物直接成本為920億美元,根據2002年美國糖尿病協會的數字。 Vinnova's funding will be spread over a ten-year period, with addition funding coming from industry and the regional government (Region Skane), with a number of companies already signed up, according to a release. An increasing number of specialist research centres are sprouting up across Europe in response to the growth of obesity and related conditions. Indeed, only last week this website reported on a UK research hub, which could help inform government policy on the very real issues brought on by the growing obesity problem. The Centre for Preventive Medicine officially opens its doors on Tuesday in Norwich and will bring together the expertise of the University of East Anglia (UEA) and the Institute of Food Research. Such a move comes at a time when medical problems associated with unhealthy lifestyles are putting a hefty price on health care services. The annual cost to the UK's National Health Service (NHS) for coronary heart disease is £6.3bn, while £1bn is spent on obesity related conditions.